Validation of a Diagnostic Test for Glucose-6-phosphate Dehydrogenase (G6PD) Deficiency in Anti-coagulated Blood

NACompletedINTERVENTIONAL
Enrollment

229

Participants

Timeline

Start Date

August 12, 2019

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
G6PD Deficiency
Interventions
DIAGNOSTIC_TEST

SD Biosensor STANDARD G6PD Test

The SD Biosensor G6PD Analyzer is designed to measure the quantitative determination of total hemoglobin concentration and G6PD enzymatic activity in fresh human whole blood specimens based on reflectometry assays in a point-of-care setting. The test is intended to aid in the identification of people with G6PD deficiency. The test is currently not licensed for use in the US and is considered an investigational product.

DIAGNOSTIC_TEST

Pointe Scientific Test Kit

The Pointe Scientific test kit will serve as the reference assay to assess G6PD activity. Its intended use is for the quantitative, kinetic determination of G6PD in blood at 340 nm.

DIAGNOSTIC_TEST

HemoCue System

The HemoCue hemoglobin (Hb) 201+ system is designed for quantitative point-of-care whole blood hemoglobin determination in primary care using a specially designed analyzer, the HemoCue Hb 201+ Analyzer, and specially designed microcuvettes, the HemoCue Hb 201+Microcuvettes.

Trial Locations (1)

19602

BSC corporation, Reading

All Listed Sponsors
lead

PATH

OTHER

NCT04054661 - Validation of a Diagnostic Test for Glucose-6-phosphate Dehydrogenase (G6PD) Deficiency in Anti-coagulated Blood | Biotech Hunter | Biotech Hunter